Westend S.A., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 507,450 shares at $12.95 ($6.6M) on 2018-06-25, disclosed to the SEC on 2018-06-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.36 | 25,461 | $340K | 5.2% |
| 2 | $13.36 | 25,461 | $340K | 5.2% |
| 3 | $12.95 | 228,264 | $3.0M | 44.8% |
| 4 | $12.95 | 228,264 | $3.0M | 44.8% |
| Total | $12.99 avg | 507,450 | $6.6M | 100% |
| Filing → |